AVDL
Price
$8.60
Change
+$0.29 (+3.49%)
Updated
Apr 24 closing price
Capitalization
1.53B
17 days until earnings call
NBIX
Price
$105.76
Change
+$2.54 (+2.46%)
Updated
Apr 24 closing price
Capitalization
13.72B
10 days until earnings call
Ad is loading...

AVDL vs NBIX

Header iconAVDL vs NBIX Comparison
Open Charts AVDL vs NBIXBanner chart's image
Avadel Pharmaceuticals
Price$8.60
Change+$0.29 (+3.49%)
Volume$729.66K
Capitalization1.53B
Neurocrine Biosciences
Price$105.76
Change+$2.54 (+2.46%)
Volume$1.3M
Capitalization13.72B
AVDL vs NBIX Comparison Chart
Loading...
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVDL vs. NBIX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVDL is a Buy and NBIX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (AVDL: $8.60 vs. NBIX: $105.76)
Brand notoriety: AVDL: Notable vs. NBIX: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AVDL: 64% vs. NBIX: 86%
Market capitalization -- AVDL: $1.53B vs. NBIX: $13.72B
AVDL [@Pharmaceuticals: Other] is valued at $1.53B. NBIX’s [@Pharmaceuticals: Other] market capitalization is $13.72B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVDL’s FA Score shows that 0 FA rating(s) are green whileNBIX’s FA Score has 0 green FA rating(s).

  • AVDL’s FA Score: 0 green, 5 red.
  • NBIX’s FA Score: 0 green, 5 red.
According to our system of comparison, AVDL is a better buy in the long-term than NBIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVDL’s TA Score shows that 6 TA indicator(s) are bullish while NBIX’s TA Score has 5 bullish TA indicator(s).

  • AVDL’s TA Score: 6 bullish, 4 bearish.
  • NBIX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both AVDL and NBIX are a good buy in the short-term.

Price Growth

AVDL (@Pharmaceuticals: Other) experienced а +7.10% price change this week, while NBIX (@Pharmaceuticals: Other) price change was +4.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.30%. For the same industry, the average monthly price growth was -2.30%, and the average quarterly price growth was -8.27%.

Reported Earning Dates

AVDL is expected to report earnings on Aug 06, 2025.

NBIX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+4.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($13.7B) has a higher market cap than AVDL($1.53B). AVDL YTD gains are higher at: -18.173 vs. NBIX (-22.520). NBIX has higher annual earnings (EBITDA): 358M vs. AVDL (-149.12M). NBIX has more cash in the bank: 1.03B vs. AVDL (105M). AVDL has less debt than NBIX: AVDL (2.62M) vs NBIX (428M). NBIX has higher revenues than AVDL: NBIX (1.89B) vs AVDL (28M).
AVDLNBIXAVDL / NBIX
Capitalization1.53B13.7B11%
EBITDA-149.12M358M-42%
Gain YTD-18.173-22.52081%
P/E RatioN/A57.20-
Revenue28M1.89B1%
Total Cash105M1.03B10%
Total Debt2.62M428M1%
FUNDAMENTALS RATINGS
AVDL vs NBIX: Fundamental Ratings
AVDL
NBIX
OUTLOOK RATING
1..100
618
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
9557
PRICE GROWTH RATING
1..100
6381
P/E GROWTH RATING
1..100
4291
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NBIX's Valuation (71) in the Biotechnology industry is in the same range as AVDL (79) in the Medical Specialties industry. This means that NBIX’s stock grew similarly to AVDL’s over the last 12 months.

NBIX's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as AVDL (100) in the Medical Specialties industry. This means that NBIX’s stock grew similarly to AVDL’s over the last 12 months.

NBIX's SMR Rating (57) in the Biotechnology industry is somewhat better than the same rating for AVDL (95) in the Medical Specialties industry. This means that NBIX’s stock grew somewhat faster than AVDL’s over the last 12 months.

AVDL's Price Growth Rating (63) in the Medical Specialties industry is in the same range as NBIX (81) in the Biotechnology industry. This means that AVDL’s stock grew similarly to NBIX’s over the last 12 months.

AVDL's P/E Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for NBIX (91) in the Biotechnology industry. This means that AVDL’s stock grew somewhat faster than NBIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVDLNBIX
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
62%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 17 days ago
61%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
73%
View a ticker or compare two or three
Ad is loading...
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLAAX40.680.36
+0.89%
Value Line Asset Allocation Investor
JRASX71.08N/A
N/A
Janus Henderson Research S
GCEAX16.58N/A
N/A
AB Global Core Equity A
PJDAX16.20N/A
N/A
PGIM Jennison Rising Dividend A
MRIMX20.99N/A
N/A
Victory Integrity Mid-Cap Value R6

AVDL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVDL has been loosely correlated with RMTI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AVDL jumps, then RMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVDL
1D Price
Change %
AVDL100%
+3.49%
RMTI - AVDL
35%
Loosely correlated
+3.48%
PAHC - AVDL
25%
Poorly correlated
+4.77%
LIEN - AVDL
24%
Poorly correlated
+2.42%
RDY - AVDL
23%
Poorly correlated
+2.34%
NBIX - AVDL
23%
Poorly correlated
+2.46%
More

NBIX and

Correlation & Price change

A.I.dvisor tells us that NBIX and LFCR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBIX and LFCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBIX
1D Price
Change %
NBIX100%
+2.46%
LFCR - NBIX
32%
Poorly correlated
-2.68%
EOLS - NBIX
30%
Poorly correlated
+2.85%
ACET - NBIX
25%
Poorly correlated
+2.13%
HROW - NBIX
24%
Poorly correlated
+5.20%
ALKS - NBIX
24%
Poorly correlated
+1.92%
More